Dr. Kaner is the Director of the Inpatient Leukemia Service at Weill Cornell Medicine. He is also Director of the HLH Consult service and the HLH clinical and translational research program. He specializes in the diagnosis and management of inpatients with acute leukemias (ALL,AML, APL, MPAL, AUL), and other bone marrow disorders including aplastic anemia, MDS, CML, MPN and HLH. In addition, Dr. Kaner is the Associate Director of the Hematology and Medical Oncology Fellowship Program.
Dr. Kaner is a clinical investigator and focuses his clinical and research practice on improving outcomes for patients with various types of acute leukemia and hemophagocytic lymphohistiocytosis.